Skip to content

Back to the catalog

STUART: Sequence Triage and qUAntification of Read Transcripts for Rapid Ionizing Radiation Exposure Assessment
arxiv.orgpaper

STUART: Sequence Triage and qUAntification of Read Transcripts for Rapid Ionizing Radiation Exposure Assessment

STUART is a mapping-free machine learning framework for biological dosimetry that converts raw sequencing reads into k-mer-based numerical feature profiles (NLP-inspired), bypassing traditional alignment-based bioinformatics. Using the FDXR gene as a radiation biomarker, the authors compare Logistic Regression, Random Forest, and XGBoost, reducing a 1024-dimensional feature space by over 98% to as few as 17 signatures while achieving 95-100% F1/balanced accuracy and over 99% specificity on external validation, enabling real-time triage compatible with portable sequencers.

TL;DR A k-mer/ML classifier (LR, RF, XGBoost) replaces sequence alignment for rapid, portable radiation-exposure triage from transcriptomic reads.
Document

What it claims

The page's abstract adds one operationally significant number the catalog summary omits: complete signal stabilization requires aggregating merely ~1000 potentially related reads. This is the threshold that makes the "analyze-as-you-sequence" paradigm plausible on portable sequencers — it tells you how much data must accumulate before a classification is trustworthy, not just how accurate the final classifier is. The summary gives you the model accuracy and the 17-signature feature count but never states the data volume needed to reach them.

Evidence

As stated in the abstract:

  • Initial feature space of 1024 dimensions, reduced by over 98% via signature-selection strategies, down to as few as 17 retained transcriptomic signatures.
  • Balanced accuracy and F1-scores in the 95–100% range across Logistic Regression, Random Forest, and XGBoost.
  • Learning-curve analysis: signal stabilizes at ~1000 aggregated reads — the low data threshold that underpins the real-time claim.
  • External validation on an independent dataset: >99% specificity, which the authors read as evidence the signatures are tissue-agnostic (validation cells had different cellular origins from training).

The biomarker is the FDXR gene; the authors state the framework is architecturally applicable to any transcriptomic biomarker and that radiation is the case study, not a hard-coded dependency.

Limits

  • This is an abstract-only arXiv page (v1, submitted 16 Sep 2026). No k-mer length, no dataset sizes, no per-model breakdown, no code or data link is given in the fetched text — the "1024-dimensional" figure and the 17-signature count are stated without the method detail (e.g., which k) needed to reproduce them.
  • The tissue-agnostic and universal-biomarker claims rest on a single external dataset and the FDXR case; the abstract does not report how many classes, dose levels, or exposure conditions were tested.
  • No licence, repository, or runtime/compute figures appear on the page, so adoption cost and availability are unstated. An engineer would need the PDF to assess reproducibility.

Organisations named here

  • FDXR

Technologies named here

  • STUART
  • XGBoost
  • Logistic Regression
  • Random Forest

Techniques named here

  • k-mer-based numerical profiling
  • Advanced signature selection